|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| 27/21/27 | Patient Access Solutions, Inc. Introduces CAMEO | CI |
| 24/21/24 | Cara Therapeutics Shares Rise 7% on FDA Approval of Korsuva Injection | DJ |
| Market Cap | 3L 3L 3L 3L 5L 3.33Cr 5L 33.39L 13.05L 1.66Cr 13.14L 12.85L 5.51Cr | P/E 2007 * |
-
| P/E 2008 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.85L 12.03L 11.22L 10.3L 19.49L 13Cr 19.7L 1.32Cr 51.69L 6.59Cr 52.03L 50.89L 22Cr | EV / Sales 2007 * |
-
| EV / Sales 2008 | 24.4x |
| Free-Float |
-
| Yield 2007 * |
-
| Yield 2008 | - |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.01 | |
| 10 years | 0 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Weitzberg
CEO | Chief Executive Officer | 66 | - |
Robert Linzalone
PRN | Corporate Officer/Principal | 66 | 02/02/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/04/26 | Other | 0 | 0% |
| 2007 | 2008 | |
|---|---|---|
| Net sales | 3L 3L 3L 2L 5L 3.07Cr 5L 30.8L 12.04L 1.53Cr 12.12L 11.85L 5.08Cr | 4L 3L 3L 3L 5L 3.33Cr 5L 33.44L 13.07L 1.67Cr 13.16L 12.87L 5.52Cr |
| Net income | -7L -6L -6L -5L -10L -6.52Cr -10L -65.41L -25.57L -3.26Cr -25.73L -25.17L -11Cr | -90.9L -78.93L -73.59L -67.61L -1.28Cr -86Cr -1.29Cr -8.68Cr -3.39Cr -43Cr -3.41Cr -3.34Cr -143.22Cr |
| Net Debt | 12.74L 11.06L 10.31L 9L 17.92L 12Cr 18.11L 1.22Cr 47.53L 6.06Cr 47.83L 46.79L 20Cr | 10.36L 9L 8L 8L 14.57L 9.85Cr 14.73L 98.85L 38.64L 4.92Cr 38.89L 38.04L 16Cr |
Employees
5
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | $0.000001 | 0.00% | 10,000 |
| 31/26/31 | $0.000001 | 0.00% | 700 |
- Stock Market
- Stocks
- PASO Stock
Select your edition
All financial news and data tailored to specific country editions
















